VIATRIS INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
VIATRIS INC. (VTRS) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 553.69 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-08-06
- VIATRIS INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-06-30 was 88.09K shares, a 74.90% decline year-over-year.
- VIATRIS INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-03-31 was 465.60K shares, a 183.57% increase year-over-year.
- VIATRIS INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-12-31 was 263.24K shares, a 240.84% increase year-over-year.
- VIATRIS INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-09-30 was 93.11K shares, a 34.41% decline year-over-year.
- VIATRIS INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 871.44K shares, a 16.10% increase from fiscal 2024.
- VIATRIS INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 750.60K shares, a 37.17% increase from fiscal 2023.
- VIATRIS INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 547.21K shares, a 51.44% decline from fiscal 2022.
- VIATRIS INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 1.13M shares, a 0.74% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | 88.09K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | 553.69K shares 10-Q · filed 2026-08-06 | 816.93K shares derived: sum of 3 quarters · filed 2026-08-06 | 910.04K shares derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 465.60K shares 10-Q · filed 2026-05-07 | 728.84K shares derived: sum of 2 quarters · filed 2026-05-07 | 821.95K shares derived: sum of 3 quarters · filed 2026-05-07 | 1.17M shares derived: sum of 4 quarters · filed 2026-05-07 |
| 2025-12-31 | 263.24K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 356.35K shares derived: sum of 2 quarters · filed 2026-02-26 | 707.25K shares derived: sum of 3 quarters · filed 2026-02-26 | 871.44K shares 10-K · filed 2026-02-26 |
| 2025-09-30 | 93.11K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | 444.01K shares derived: sum of 2 quarters · filed 2025-11-06 | 608.20K shares 10-Q · filed 2025-11-06 | 685.44K shares derived: sum of 4 quarters · filed 2025-11-06 |
| 2025-06-30 | 350.90K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | 515.10K shares 10-Q · filed 2025-08-07 | 592.33K shares derived: sum of 3 quarters · filed 2025-08-07 | 734.28K shares derived: sum of 4 quarters · filed 2025-08-07 |
| 2025-03-31 | 164.19K shares 10-Q · filed 2025-05-08 | 241.43K shares derived: sum of 2 quarters · filed 2025-05-08 | 383.38K shares derived: sum of 3 quarters · filed 2025-05-08 | 496.87K shares derived: sum of 4 quarters · filed 2025-05-08 |
| 2024-12-31 | 77.23K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | 219.19K shares derived: sum of 2 quarters · filed 2025-02-27 | 332.68K shares derived: sum of 3 quarters · filed 2025-02-27 | 750.60K shares 10-K · filed 2025-02-27 |
| 2024-09-30 | 141.96K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | 255.45K shares derived: sum of 2 quarters · filed 2024-11-07 | 673.36K shares 10-Q · filed 2024-11-07 | 784.96K shares derived: sum of 4 quarters · filed 2025-02-27 |
| 2024-06-30 | 113.49K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | 531.41K shares 10-Q · filed 2024-08-08 | 643.00K shares derived: sum of 3 quarters · filed 2025-02-27 | 742.82K shares derived: sum of 4 quarters · filed 2025-02-27 |
| 2024-03-31 | 417.92K shares 10-Q · filed 2024-05-09 | 529.51K shares derived: sum of 2 quarters · filed 2025-02-27 | 629.33K shares derived: sum of 3 quarters · filed 2025-02-27 | 722.96K shares derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-12-31 | 111.60K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | 211.41K shares derived: sum of 2 quarters · filed 2025-02-27 | 305.05K shares derived: sum of 3 quarters · filed 2025-02-27 | 547.21K shares 10-K · filed 2025-02-27 |
| 2023-09-30 | 99.82K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | 193.45K shares derived: sum of 2 quarters · filed 2023-11-08 | 435.62K shares 10-Q · filed 2023-11-08 | 575.33K shares derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | 93.63K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | 335.80K shares 10-Q · filed 2023-08-07 | 475.51K shares derived: sum of 3 quarters · filed 2025-02-27 | 679.91K shares derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | 242.16K shares 10-Q · filed 2023-05-08 | 381.88K shares derived: sum of 2 quarters · filed 2025-02-27 | 586.28K shares derived: sum of 3 quarters · filed 2025-02-27 | 918.85K shares derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | 139.71K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | 344.11K shares derived: sum of 2 quarters · filed 2025-02-27 | 676.69K shares derived: sum of 3 quarters · filed 2025-02-27 | 1.13M shares 10-K · filed 2025-02-27 |
| 2022-09-30 | 204.40K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | 536.97K shares derived: sum of 2 quarters · filed 2022-11-07 | 987.13K shares 10-Q · filed 2022-11-07 | 1.12M shares derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | 332.57K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | 782.74K shares 10-Q · filed 2022-08-08 | 915.09K shares derived: sum of 3 quarters · filed 2024-02-28 | 979.45K shares derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | 450.16K shares 10-Q · filed 2022-05-09 | 582.51K shares derived: sum of 2 quarters · filed 2024-02-28 | 646.88K shares derived: sum of 3 quarters · filed 2024-02-28 | 779.15K shares derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | 132.35K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | 196.72K shares derived: sum of 2 quarters · filed 2024-02-28 | 328.99K shares derived: sum of 3 quarters · filed 2024-02-28 | 1.14M shares 10-K · filed 2024-02-28 |
| 2021-09-30 | 64.36K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | 196.64K shares derived: sum of 2 quarters · filed 2021-11-08 | 1.00M shares 10-Q · filed 2021-11-08 | |
| 2021-06-30 | 132.27K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | 938.52K shares 10-Q · filed 2021-08-09 | ||
| 2021-03-31 | 806.25K shares 10-Q · filed 2021-05-10 | |||
| 2020-12-31 | 422.71K shares 10-K · filed 2023-02-27 | |||
| 2019-12-31 | 715.94K shares 10-K · filed 2022-02-28 | |||
| 2018-12-31 | 468.07K shares 10-K · filed 2021-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |